Afferent Pharmaceuticals
Clinical-stage biopharmaceutical company that develops medicines to treat chronic pain. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
CAD300—450m (Dealroom.co estimates Jul 2015.)
Boston Massachusetts (HQ)
Authorizing premium user...